Medford, MA, United States of America

Stephanie Hennek

This inventor holds 1 USPTO granted patent. Top assignee: Pathai, Inc.. Active years: 2026.


% Patents Active = 100.0

Average Co-Inventor Count = 27.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Stephanie Hennek: Innovator in Predictive Healthcare Technology

Introduction

Stephanie Hennek is a notable inventor based in Medford, MA (US). She has made significant contributions to the field of healthcare technology, particularly in the area of predictive analytics for disease severity.

Latest Patents

Hennek holds a patent for "Systems and methods for predicting disease severity in ulcerative colitis." This innovative patent describes a method, system, or non-transitory computer-readable storage medium for training models to predict ulcerative colitis (UC) severity. The process involves accessing a plurality of annotated whole-slide images associated with UC patients, extracting human-interpretable image features, and training a statistical model to predict UC severity based on these features. This advancement has the potential to enhance patient care by providing more accurate predictions of disease severity.

Career Highlights

Stephanie Hennek is currently employed at Pathai, Inc., where she continues to develop innovative solutions in healthcare technology. Her work focuses on leveraging machine learning and image analysis to improve disease prediction and management.

Collaborations

Hennek collaborates with talented professionals such as Fedaa Najdawi and Kathleen Sucipto, contributing to a dynamic team dedicated to advancing healthcare solutions.

Conclusion

Stephanie Hennek's work exemplifies the intersection of technology and healthcare, showcasing her commitment to improving patient outcomes through innovation. Her contributions are paving the way for more effective disease management strategies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…